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Objective: In 2015, we conducted at 44 healthcare facilities (HCFs) and 21 nursing
homes (NHs) a 3-month bloodstream infection (BSI) survey, and a 1-day prevalence
study to determine the rate of carriage of methicillin-resistant Staphylococcus aureus
(MRSA) in 891 patients and 470 residents. We investigated the molecular characteristics
of the BSI-associated and colonizing MRSA isolates, and assessed cross-transmission
using double-locus sequence typing and pulsed-field gel electrophoresis protocol.
Results: The incidence of MRSA-BSI was 0.040/1000 patient-days (19 cases). The
prevalence of MRSA carriage was 4.2% in patients (n = 39) and 8.7% in residents
(n = 41) (p < 0.001). BSI-associated and colonizing isolates were similar: none were
PVL-positive; 86.9% belonged to clonal complexes 5 and 8; 93.9% were resistant to
fluoroquinolones. The qacA/B gene was carried by 15.8% of the BSI-associated isolates
[3/3 BSI cases in intensive care units (ICUs)], and 7.7% of the colonizing isolates in
HCFs. Probable resident-to-resident transmission was identified in four NHs.
Conclusion: Despite generally reassuring results, we identified two key concerns. First,
a worryingly high prevalence of the qacA/B gene in MRSA isolates. Antisepsis measures
being crucial to prevent healthcare-associated infections, our findings raise questions
about the potential risk associated with chlorhexidine use in qacA/B+ MRSA carriers,
particularly in ICUs. Second, NHs are a weak link in MRSA control. MRSA spread was
not controlled at several NHs; because of their frequent contact with the community,
conditions are favorable for these NHs to serve as reservoirs of USA300 clone for local
HCFs.
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INTRODUCTION
Methicillin-resistant Staphylococcus aureus (MRSA) infections
have long been associated with healthcare facilities (HCFs) and
remain a matter of concern, due to the morbidity and mortality
associated with the infections they cause (de Kraker et al., 2011).
Over the last 20 years, the adherence of healthcare workers to
infection control guidelines for patients with MRSA carriage
has improved. This approach has proved eﬀective, leading to
a marked decrease in the incidence of healthcare-associated
infections (HAIs) due to MRSA (Cooper et al., 2004; McGinigle
et al., 2008; Rolain et al., 2015).
However, the epidemiology of MRSA is changing, with
the worldwide spread of Panton-Valentine leukocidin (PVL)-
producing MRSA previously implicated only in infections in
patients with no history of healthcare (Boyce, 2008; Popovich
et al., 2008). The spread of the ST8-USA300 clone is a matter of
particular concern. These MRSA isolates are increasingly being
implicated in HAIs (Tenover and Goering, 2009). In France,
infections associated with PVL-producing MRSA remain rare
(Robert et al., 2011). However, two clusters of ST8-USA300
infections were recently described, one in a rehabilitation care
center (Fournier, 2013) and the other in a residential home (Haut
Conseil de la Santé Publique, 2014).
We investigated epidemiological changes in the large “Centre
Val de Loire” region (2.6 million inhabitants), assessing MRSA
infection and colonization in the elderly, by conducting
a multicenter study. We conducted a 3-month survey of
bloodstream infections (BSI) associated with MRSA, and a
1-day prevalence study of MRSA carriage in patients and
residents. We studied the molecular characteristics of the
BSI-associated and colonizing MRSA isolates, and assessed
cross-transmission within institutions using molecular typing
tools. In addition, chlorhexidine resistance in MRSA being an
emerging threat (Edgeworth, 2011), the MRSA isolates were
screened for the presence of the qacA/B gene, i.e., the genetic
determinant for eﬄux-mediated resistance to chlorhexidine
(Poole, 2005).
MATERIALS AND METHODS
Survey of Bloodstream Infection
A 3-month survey of all cases of BSI was conducted at 47
HCFs (45 hospitals and two home hospitalization centers) and
nine independent nursing homes (NHs) between January 1 and
March 31 2015. These institutions had a total of 7,381 short-
stay beds, 2,187 rehabilitation care beds and 8,549 long-stay beds.
The survey covered 473,600 patient-days (PDs) in short-stay
units, 134,428 PDs in rehabilitation care units and 70,966 PDs in
long-stay units.
The methods used and the design of this study have
been reported elsewhere (van der Mee-Marquet et al., 2007).
Brieﬂy, BSI was deﬁned as a positive blood culture from
a patient with clinical or laboratory evidence of infection.
The variables reported included patient age and sex, origin
of the BSI and occurrence of death within 7 days of BSI
diagnosis. All S. aureus isolates from BSI cases were sent
to the central laboratory for extensive study. Identiﬁcation
was conﬁrmed by MALDI-TOF MS (bioMérieux, France).
Antimicrobial drug susceptibility testing was performed by the
agar disk diﬀusion method (Comité de l’Antibiogramme de
la Société Française de Microbiologie, 2015). The antibiotics
tested were penicillin G, oxacillin, erythromycin, lincomycin,
pristinamycin, tetracycline, kanamycin, tobramycin, gentamicin,
rifampin, fusidic acid, fosfomycin, peﬂoxacin and cotrimoxazole.
Vancomycin, teicoplanin and mupirocin Minimum Inhibitory
Concentration values were determined using E-test method
(bioMérieux, France). PCR assays were used to conﬁrm the
presence of the mecA gene (Cuny et al., 2011) and to detect
the lukS-PV and lukF-PV genes (Jarraud et al., 2002) and the
genetic determinant for chlorhexidine resistance qacA/B (Fritz
et al., 2013). MRSA isolates were typed using pulsed-ﬁeld gel
electrophoresis protocol (Murchan et al., 2003), and double-locus
sequence typing (DLST) (Basset et al., 2010). DLST-types were
assigned according to the DLST database (www.DLST.org). Using
eBURST algorithm, the relatedness between isolates was deﬁned
by clustering all DLST-types sharing one of the two alleles.
Carriage Study
The study was conducted at the 56 institutions participating in
the BSI study. The HCFs had medical, surgical and rehabilitation
care units, and at least one NH unit. For the 45 HCFs, we ﬁrst
selected one unit at random. We then selected 30 individuals
from this unit at random, for participation in the study. We
selected 30 individuals at random from each of the independent
NHs and home hospitalization centers. All the patients and
residents present in the institutions between January and March
2015 were eligible for recruitment. They (or their relatives) were
approached individually and asked for consent to access their
medical records and to culture a sample to test for S. aureus.
The 1-day point-prevalence study was carried out between
January 1 and March 31 2015. Each patient or resident was
included only once. Microbiological samples were collected from
all the individuals included. Patients and residents were screened
for S. aureus carriage by nasal swabbing (both nostrils). The swabs
were placed in 0.5 ml of sterile water and 0.1 ml of the resulting
suspension was streaked onto a Chapman selective agar plate
(bioMérieux, France). The plates were incubated for 48 h at 35◦C.
The identiﬁcation and molecular characterization of S. aureus
and MRSA isolates were as described for the BSI study.
Data were collected on a standardized questionnaire, for
all the individuals enrolled in the study. They included
demographic data (age and sex), physical disability and
signiﬁcant comorbidities, and various risk factors for MRSA
carriage (hospitalization and antibiotic use in the month
preceding inclusion in the study).
Univariate analyses were carried out with χ2 or Fisher’s exact
tests, as appropriate, for categorical variables and Student’s t-test
or Kruskall–Wallis test for continuous variables. All statistical
tests were two-tailed. We considered p-values <0.05 to be
statistically signiﬁcant. We used EpiInfo version 6 software
and Stata software version 10 (StataCorp., USA) for statistical
analysis.
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Confidentiality and Ethical Aspects
The study was carried out in accordance with French
recommendations for the prevention of infection in healthcare.
Ethical approval was obtained at the national level, from
the Réseau Alerte Investigation Surveillance des Infections
Nosocomiales (RAISIN). The study was managed jointly with
the directors of the HCFs and NHs, the hygiene nurses and the
physicians responsible for caring for the patients/residents, and
the regional infection control team.
RESULTS
BSI Study
Epidemiology
Nineteen cases of BSI due to MRSA were identiﬁed, 12 in male
patients and seven in female patients hospitalized in short-stay
units, including three in intensive care units (ICUs). This resulted
in an incidence rate of 0.040/1,000 PDs. The BSI was associated
with endocarditis (n = 1), infections of the skin (n = 5), lungs
(n = 4), the urinary tract (n = 3), a surgical site (n = 2) or an
intravenous device (n = 4). Most of the patients had a recent
history of hospitalization (63.2%), and of antibiotic treatment
(42.1%); one patient lived in a NH (5.3%). The early mortality
rate was 21.0%.
Molecular Characteristics of the BSI Isolates
The PVL gene was not detected in the 19 isolates studied. All
but one of the MRSA isolates were resistant to ﬂuoroquinolones
(94.7%) (Supplementary Table S1); 12 were resistant only to
methicillin and ﬂuoroquinolones (63.2%). Eburst clustering
revealed two major clusters: one comprising 9 (47.5%) isolates
from clonal complex (CC) 5 and the other containing 8
isolates from CC8 (42.1%) (Figure 1). The qacA/B gene was
detected in three isolates (15.8%) recovered from the three
patients hospitalized in diﬀerent ICUs (Supplementary Table S1,
Figure 1). One had a BSI of surgical origin, and the other two
had BSI of pulmonary origin, developing during the course of
mechanical ventilation. For these two cases, chlorhexidine mouth
washes were carried out daily during hospitalization.
Carriage Study
Population Characteristics
Sixty-ﬁve units participated in the study (Table 1); 921 patients
and 470 residents were enrolled in the study: 819 women (58.9%)
and 572 men (41.1%). The population was elderly (median age:
82 years) and had a poor health status, with 40.3% of individuals
having a McCabe index of 1 or 2 (fatal illness likely to occur
within the next 5 years). Cancer and immunodepression were
reported in 10.4 and 8.1% of the study subjects, respectively.
A recent history of urinary catheterization or of the insertion
of an intravenous device was reported for 4.9 and 14.7% of
the subjects studied, respectively. In addition, 14.4% of the
individuals had recently been treated with antibiotics, and, 13.6%
presented signs of infection on the day of the study. The
clinical characteristics diﬀered signiﬁcantly between patients and
residents. The very elderly population of residents had a better
health status, with signiﬁcantly fewer comorbid conditions than
the population of patients (Table 1). Among patients, those
hospitalized in surgical units were younger (p < 0.001) and had
a better health status than those from medical and rehabilitation
care units.
MRSA Carriage
Staphylococcus aureus carriage was found in 213 patients (23.1%)
and 130 residents (27.6%); 39 patients (4.2%) and 41 residents
(8.7%) were found to be MRSA carriers. The carriage rate was
between 0 and 25.0%, depending on the unit considered, and
was higher in residents than in patients (p < 0.001) (Table 2).
A carriage rate >10.0% was observed in 15.9% of the HCF
units and in 42.9% of the NH units (p < 0.018). Among
patients, the MRSA carriage rate was lower in surgical units
(p = 0.005). Twelve of the 80 MRSA carriers (15.0%) presented
signs of infection on the day of the study, but staphylococcal
infection was unlikely in all the cases. MRSA carriers were
older than the patients not carrying MRSA (p = 0.003) and
they also had a poorer health status: MRSA carriers were more
likely to have a McCabe index of 1 or 2 (p = 0.017), cancer
(p = 0.037) or an infection (p = 0.030) (Table 2). Among
residents, MRSA colonization was associated with poorer health
status (p = 0.022) and recent antibiotic treatment (p = 0.013)
(Table 2). The residents and patients did not diﬀer in terms of
clinical characteristics, except for median age (p = 0.006).
Molecular Characteristics of Colonizing MRSA
Isolates
The PVL gene was not detected in the 80 isolates studied.
Most of the 80 isolates were resistant to ﬂuoroquinolones
(93.7%; Supplementary Table S1). Fifty-one isolates (63.8%) were
resistant only to methicillin and ﬂuoroquinolones. DLST of the
80 isolates identiﬁed 34 DLST-types (Figure 1). Like the BSI
isolates, most colonizing isolates formed two major clusters,
one comprising 35 (43.7%) isolates from CC5 and the other
containing 34 isolates from CC8 (42.5%). The isolates colonizing
residents were associated with CC5 whereas those from patients
were associated with CC8 (p = 0.044). The qacA/B gene was
detected in three of the 39 isolates recovered from patients (7.7%)
(Supplementary Table S1, Figure 1); high level of resistance to
mupirocin (MIC value > 1024 mg/L) was observed in one of
these 39 isolates (2.6%) (Chaves et al., 2004). Isolates carrying
the qacA/B gene or mupirocin resistant were not recovered from
residents.
Spread of MRSA Within Institutions
In 12 cases, two or more isolates of the same DLST-type were
recovered from individuals from the same unit (Supplementary
Table S2). In four NH units, the isolates with similar DLST-types
also yielded similar PFGE patterns, suggesting an epidemiological
link between the isolates and cross-transmission within the NH.
The rate of MRSA carriage at these four NH units exceeded
11.0%. Separation of the 65 participating units into two groups
on the basis of carriage rate (below or above 10%) revealed an
association between possible cross-transmission and the group of
units with the highest carriage rates (p = 0.003).
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FIGURE 1 | Double locus sequence typing (DLST) single locus variant (SLV) clustering using eBurst on the 19 BSI-associated and 80 colonizing
MRSA isolates. Each circle represents one DLST-type and the number of the squares reflects the frequency of that type among colonizing (in blue) or
BSI-associated isolates (in red). Each green halo indicates possible epidemiologically related isolates and black halo indicates isolates carrying qacA/B gene. Linked
DLST-type differ at one of the two loci (clfB or spa).
DISCUSSION
Outside of the context of PVL-producing MRSA spread, data
concerning MRSA in elderly are scarce. We report a large-scale
multicenter study of MRSA BSI and carriage in elderly people
and provide insight into the current epidemiology of MRSA. Our
ﬁndings were generally reassuring.
Consistent with results of other studies (March et al., 2009;
Köck et al., 2010; Bellini et al., 2015), we found a low incidence
of MRSA-BSI in our region, an overall MRSA carriage rate of
4.2% in patients and 8.7% in residents, and a signiﬁcant link
between MRSA BSI or carriage and very old individuals with
numerous comorbid conditions, recent antibiotic exposure and
infection.
Concordant with previous studies, colonizing and infecting
isolates were genetically similar (Robinson and Enright, 2003;
Safdar and Bradley, 2008), and the isolates were equally
distributed among the major pandemic CCs CC5 and CC8 (Eko
et al., 2015). MRSA belonging to CC8 were mostly resistant
to ﬂuoroquinolones, erythromycin and aminoglycosides, while
most of isolates of CC5 were only resistant to ﬂuoroquinolones.
DLST analysis indicated wide heterogeneity among the studied
isolates, apart from a particular clone characterized by a unique
DLST-type (i.e., 42–163) and clustering one third of the MRSA
isolates recovered from colonized and infected patients/residents
hospitalized into highly diverse HCIs and NHs. These ﬁndings
suggest a successful clone spreading into our region.
We detected no colonizing MRSA isolates from the USA300
clone in the nasal ﬂora of the 1391 subjects enrolled. Despite
the limitations of our study design, such as the use of a
single nasal screening (McKinnell et al., 2013; Warnke et al.,
2014), our ﬁndings suggest that the spread of this clone has
not yet signiﬁcantly aﬀected the institutions in our region,
whereas clusters of infections associated with this clone have
recently been detected in France (Fournier, 2013; Haut Conseil
de la Santé Publique, 2014). However, we identiﬁed two key
concerns.
A Worryingly High Prevalence of the
qacA/B Gene in MRSA Isolates
The application of “search and isolate” or “search and destroy”
policies for MRSA carriers in ICUs, and the isolation of
patients infected with MRSA in all HCFs have resulted in
a decrease in the incidence of infections caused by MRSA
(McDanel et al., 2013). In this context, chlorhexidine is
increasingly used, especially as an antiseptic for skin and mucosal
membranes in HCFs, and for daily mouth wash in ICUs
(Milstone et al., 2008; Batra et al., 2010). Bacterial survival
following exposure to antiseptics has been recognized and
mechanisms conferring decreased susceptibility to antiseptics
have been identiﬁed (Harbarth et al., 2014). Recent studies
have described unintended consequences following the use of
chlorhexidine. First, the presence of the qacA/B gene has been
associated with unsuccessful decolonization during an ICU-
based topical chlorhexidine intervention (Lee et al., 2011);
second, the prevalence of reduced chlorhexidine susceptibility
has been shown to be high in organisms causing central
line-associated BSIs in ICUs in which patients are bathed
daily with chlorhexidine (Suwantarat et al., 2014); and third,
a MRSA isolate that carried the qacA/B gene and had
chlorhexidine MBC threefold higher compared with other
strains circulating on the unit, was selected following the
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TABLE 1 | Demographic, clinical characteristics and MRSA carriage of the 921 patients and 470 residents enrolled in the MRSA carriage study.
Healthcare facilities
medical unit
Surgical unit Rehab.1 Other units2 Nursing homes
Participating units 11 9 20 4 21
Patients/residents 354 280 794 229 1276
Patients/residents enrolled 206 185 452 78 470
Median age in years (gender) 85 (F)
82 (M)
73 (F)
69 (M)
82 (F)
75 (M)
64 (F)
69 (M)
88 (F)
83 (M)
McCabe index 1–2 (%) 51.6 13.0 37.1 68.9 41.9
Cancer (%) 13.2 4.4 13.6 19.5 7.1
Immunodepression (%) 9.7 2.2 10.5 37.7 2.6
Recent history of
urinary catheterization (%)
10.2 7.1 4.5 10.7 1.5
Intravenous device use (%) 36.4 38.6 6.4 14.7 3.6
Antibiotic treatment (%) 43.2 14.6 13.3 8.0 5.1
Signs of infection on the day of the
study (%)
41.0 10.4 12.6 4.0 5.5
Staphylococcus aureus carriers (%) 41 (19.9) 44 (23.8) 108 (23.9) 20 (25.6) 130 (25.7)
MSSA carriers (%) 30 (14.6) 43 (23.2) 85 (18.8) 16 (20.5) 89 (18.9)
MRSA carriers (%) 11 (5.3) 1 (0.5) 23 (5.1) 4 (5.1) 41 (8.7)
1Rehabilitation unit. 2One dialysis unit, two home hospitalization centers, one psychiatry unit.
TABLE 2 | Characteristics of the 921 patients and 470 residents enrolled in the MRSA carriage study, by MRSA carriage status.
Healthcare facilities MRSA carriers MSSA carriers S.aureus non-carriers MRSA non-carriers p∗
Number of patients 39 174 708 882
Median age (years) 83 76 79 79 0.034
McCabe index 1–2 (%) 59.0 38.5 34.2 38.6 0.017
Cancer (%) 23.1 11.5 11.4 11.6 0.037
Immunodepression (%) 18.4 10.3 10.4 10.6
Recent history of
urinary catheterization (%)
10.2 4.0 7.1 6.5
Intravenous device use (%) 25.6 23.0 22.3 20.0
Antibiotic treatment (%) 28.2 12.1 19.9 18.9
Signs of infection on the day of
the study (%)
30.8 10.3 18.4 17.2 0.030
Nursing homes
Number of residents 41 89 340 429
Median age (years) 87 88 86 86
McCabe index 1–2 (%) 51.2 35.9 36.8 33.5 0.022
Cancer (%) 7.5 6.7 7.1 7.1
Immunodepression (%) 7.5 3.4 1.8 2.1 0.075
Recent history of
urinary catheterization (%)
4.9 2.2 0.1 1.2
Intravenous device use (%) 0 3.4 4.1 3.4
Antibiotic treatment (%) 14.6 1.1 5.0 4.2 0.013
Signs of infection on the day of
the study (%)
12.2 1.1 5.9 4.9 0.066
*Comparison of MRSA carriers and MRSA non-carriers; only significant p-values are shown.
introduction of a chlorhexidine-based decolonization regimen
(Batra et al., 2010). In addition, several studies have underlined
how the presence of qacA/B gene may confer a selective
advantage in the presence of chlorhexidine use (Ho and
Branley, 2012; Otter et al., 2013). Before this study, data
about the presence of the qacA/B gene in MRSA isolates
colonizing/infecting elderly French people were not available.
The high prevalence of the qacA/B gene in BSI isolates
(3/3 cases in ICUs), and in isolates into the microbiota of
patients is worrisome. These aspects require further prospective
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investigation and continued surveillance. To date, there is a lack
of a standard deﬁnition of resistance to antiseptics, absence of
standardized methods of detection, and no systematic method
for measuring the clinical impact of reduced susceptibility to
antiseptics (Harbarth et al., 2014). Our ﬁndings raise questions
about the relationship between the carriage of chlorhexidine
eﬄux-mediated resistance genes and reduced chlorhexidine
susceptibility, and about the potential risk associated with
chlorhexidine use in qacA/B+ MRSA carriers, particularly
in ICUs. Reduced susceptibility to antiseptics could become
an increasing problem; its clinical impact needs further
research.
NHs Remain a Weak Link in MRSA
Control
The relatively low rates of MRSA carriage masked diﬀerent
situations: rates ranged from 0 to 25.0% in participating units,
whereas the prevalence of comorbid conditions and risk factors
were similar for all units and could not account for the
observed diﬀerences. The spread of MRSA was controlled in
most participating NH units. Whereas this occurred without the
application of a “search and isolate” strategy for MRSA carriers in
these NHs. This indirectly conﬁrm that in NHs, where invasive
care procedures are rare and generally concern residents in
reasonable health, the application of standard precautions during
care procedures and the respect of basic hand hygiene measures
by all staﬀ and, as far as possible, by the residents, prevent the
resident-to-resident transmission of MRSA.
Colonizing isolates carried by more than one resident yielded
similar DLST types in several NHs, suggestive of intra-NH
resident-to-resident transmission. However, the design of our
study does not allow to various other possibilities to be excluded,
for example, importation from acute care settings that cared
the many of the residents. In HCFs, the colonizing isolates
were genetically diverse, probably reﬂecting better respect of
hygiene rules in HCFs, whereas standard precautions remain
inconsistently applied in NHs (Cochard et al., 2014). In NHs,
the risk of infection is low and infections are rare. Consequently,
the care staﬀ does not apply hygiene practices rigorously
when caring for the residents and between cares acts for
diﬀerent residents, and MRSA may spread on their hands. In
addition, unlike patients conﬁned to bed in HCFs, residents
frequently interact with other residents, thereby spreadingMRSA
via their hands if their hand hygiene is not of quality. In
situations in which residents are repeatedly hospitalized, the
NHs may serve as reservoirs of MRSA for the local HCFs.
Because of their frequent contact with the community in which
the USA300 clone is spreading, the NHs could serve as a
site for the spread of this troublesome clone in the near
future in the absence of signiﬁcant improvements in preventive
measures.
This argues for continual eﬀorts to prevent the spread of
MRSA in NHs. Education is required to promote hand hygiene,
the appropriate use of gloves and the restriction of glove use
when not required. Point-prevalence studies of carriage should
be conducted regularly in NHs, and MRSA carriage rates should
be used as a quality indicator to focus the attention of healthcare
workers on the spread of MRSA.
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